Impact of Preexisting Substance Use Disorders on Prolonged Opioid Use and Postoperative Complications After Burns
Journal of Burn Care & Research · 2025
DOI: 10.1093/jbcr/iraf098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Burn Care & Research, 2025. Verfasst von Philong Nguyen und 8 weiteren Autor:innen. Beteiligte Einrichtung: John Sealy School of Medicine, University of Texas Medical Branch, Galveston, TX 77555, United States. Hauptthemen laut MEDLINE: Burns, Substance-Related Disorders, Analgesics, Opioid, Postoperative Pain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIH HHS, UTMB Institute for Translational Sciences.
Abstract (Originalsprache)
Previous studies have linked preexisting substance use disorders (SUDs) to adverse postoperative outcomes in burn patients, yet their impact on opioid use remains unclear. This retrospective cohort study compares the effects of various substances on opioid use after burns and aims to analyze the risks and whether they differ among substances. The TriNetX database was queried for burn patients aged 18 years and older with preexisting alcohol, cannabis, or tobacco use disorders, who were placed in their respective cohorts. These patients were matched to a nonsubstance use disorder cohort using propensity score matching based on demographics, mental health, pain syndromes, and burn severity. The measured outcomes assessed were opioid use, wound infection, wound disruption, and postprocedural pain. Risk ratios and 95% confidence intervals were calculated at 3 months and 12 months postburn. After matching, patients with preexisting SUDs had significantly higher risk ratios for prolonged opioid use, wound infections, and wound healing disruptions at both 3 and 12 months compared to matched patient control cohorts. Additionally, all patient cohorts also exhibited increased risk of postprocedural pain. Burn patients with preexisting SUDs face a significantly higher risk of prolonged opioid use and postoperative complications at both 3- and 12-month postburn injury. The alcohol cohort patients were associated with the greatest increase in opioid use and postoperative complications, while the tobacco patient cohort presented with the highest wound disruption rates at 3- and 12-months postburn.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- John Sealy School of Medicine, University of Texas Medical Branch, Galveston, TX 77555, United States.
- Indiana University School of Medicine, Indianapolis, IN 46202, United States.
- University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.
- Department of Surgery, University of Texas Medical Branch, Galveston, TX 77555, United States.
ORCID-Profile: Philong Nguyen, Joshua E Lewis, Isabelle J Carroll, Joshua Wang, Mbinui Ghogomu, Blancheneige Beohon, Amina El Ayadi, Steven Wolf, Juquan Song
Förderung
- NCATS NIH HHS
- NIH HHS
- UTMB Institute for Translational Sciences
- National Institutes of Health
Zitieren
APA
Nguyen, P., Lewis, J. E., Carroll, I. J., Wang, J., Ghogomu, M., Beohon, B., El Ayadi, A., Wolf, S., & Song, J. (2025). Impact of Preexisting Substance Use Disorders on Prolonged Opioid Use and Postoperative Complications After Burns. Journal of Burn Care & Research. https://doi.org/10.1093/jbcr/iraf098
Vancouver
Nguyen P, Lewis JE, Carroll IJ, Wang J, Ghogomu M, Beohon B, et al. Impact of Preexisting Substance Use Disorders on Prolonged Opioid Use and Postoperative Complications After Burns. Journal of Burn Care & Research. 2025. doi:10.1093/jbcr/iraf098
BibTeX
@article{Nguyen2025,
author = {Nguyen, Philong and Lewis, Joshua E and Carroll, Isabelle J and Wang, Joshua and Ghogomu, Mbinui and Beohon, Blancheneige and El Ayadi, Amina and Wolf, Steven and Song, Juquan},
title = {Impact of Preexisting Substance Use Disorders on Prolonged Opioid Use and Postoperative Complications After Burns},
journal = {Journal of Burn Care & Research},
year = {2025},
doi = {10.1093/jbcr/iraf098}
}
EUVIMED